Renan Ozyerli, MD, MSD Turkey
Renan Ozyerli of MSD Turkey provides insights into the transformation of Turkey’s healthcare ecosystem over the…
MSD Turkey
Last updated: 27.07.2015
MSD entered the Turkish pharma market in 1989 and established a subsidiary in 1993.
The headquarters are based in Istanbul. MSD employs 463 people in Human Health, as well as 32 people in Animal Health. Products are sourced from the global MSD network and toll manufacturing from 4 local companies. The subsidiary has a fully operational warehouse.
Currently, MSD Turkey is participating in 23 international clinical trials at 113 study centers. As such, the affiliate ranks among the top 3 research-based pharma companies in terms of clinical research capability. MSD Turkey also houses the management oversight/responsibility of Middle East and Egypt with 6 trials and 21 study centers in 5 different countries. In 2014, Merck HQ funded TRY 20.7 million (USD 9.5 million) to Turkey for clinical trials.
Contact Details
Merck Sharp Dohme İlaçları Ltd. Şti.
Esentepe Mah. Büyükdere Cad. No: 199
Levent 199 Ofis Bloğu Kat: 13, 34394 Levent-İstanbul
Tel:+90 212 336 1000
Fax:+90 212 215 2733
http://www.msd.com.tr/
Interviews
Interview: Hatice Demiray – Managing Director, MSD Turkey
MSD Turkey has benefited in recent years from the ability to engage in local business development initiatives, and…
Related
Turkey / Abdi Ibrahim Buys 28.5% Stake in Swiss OM; A Historic Moment for Turkish Pharma
When Abdi Ibrahim acquired a 28.5 percent stake in Swiss biotech OM Pharma in September 2020, it represented a…
Company Spotlight / Acıbadem's Grand Ambitions
There is perhaps no Turkish company in the healthcare sector that is more ambitious than Acıbadem. Not only has…
Pharma Faces / Ferhat Farsi, Cinnagen
Dr Ferhat Farsi, CEO and founding partner of CinnaGen İlaç, shares his experience working for the largest biotech…
The Ideal Pharma Country Manager: Turkey (Stanton Chase)
Şükran Tümay, a senior partner at executive search and assessment firm Stanton Chase in Turkey, highlights the…
NEW Turkey Pharma Report Out Now!
Turkey – home to an 80 million-strong population, a substantial pharmaceuticals market and a universal healthcare…
Hospital Investments in Turkey: Bucking the Trend
Bucking a global trend for increased focus on outpatient and preventative care, Turkey is doubling down on…
Armağan Vurdu – General Secretary, IMMIB, Turkey
Armağan Vurdu, general secretary of the Istanbul Minerals and Metals Exporters Association (IMMIB) highlights the…
Ozlem Fidanci – CEO, Philips Middle East and Turkey
Ozlem Fidanci, CEO of the Middle East and Turkey at Philips, shares the collaborative approach Philips has…
Yelda Ulu Colin – General Manager, GE Healthcare Turkey
Yelda Ulu Colin, general manager of GE Healthcare in Turkey, offers her insider take on the country’s city…
Turkish Pharma: Eyeing Up Exports
Seizing the cost competitiveness of the Turkish market and the government’s nurturing of local manufacturing,…
Gamze Çıtıroğlu – General Manager; Murat Çıtıroğlu – Founder &…
Gamze Çıtıroğlu, Murat Çıtıroğlu and Pınar Çakır of Ekin Kimya discuss the progress of the Turkish…
Funda Gücer – Country Manager, Mylan Turkey
Funda Gücer, country manager at Mylan Turkey, portrays her experience in introducing the company to the Turkish…
